Revista brasileira de enfermagem · 2025
Impact of pharmacotherapy complexity on self-care in individuals with rheumatoid arthritis.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Matricardi Jhoniffer Lucas das Neves, Queiróz-Cardoso Andréia Insabralde de, Higa Carla Moreira Lorentz, Arruda Guilherme Oliveira de, Zulin Maria Eduarda Gonçalves, Ferreira Júnior Marcos Antonio, Ribeiro Aline Fernanda Alves
Аннотация
OBJECTIVES: to analyze the relationship between self-care and pharmacotherapy complexity in individuals with rheumatoid arthritis.
METHODS: this cross-sectional study was conducted at a teaching hospital in the Central-West region of Brazil from October to December 2023. Individuals with rheumatoid arthritis undergoing treatment for at least three months were included. A sociodemographic questionnaire, the Appraisal of Self-Care Agency Scale-Revised, and the Pharmacotherapy Complexity Index were used. Analytical statistics were applied using percentiles, the Shapiro-Wilk test, post hoc analysis, ANOVA, and the Kruskal-Wallis test.
RESULTS: the sample consisted of 96 individuals. The mean self-care and pharmacotherapy complexity scores were at intermediate levels, 56.33 and 18.29, respectively. Relationships were identified between dose frequency and self-care development, as well as between overall pharmacotherapy complexity and reduced self-care capacity.
CONCLUSIONS: a high dosage frequency may positively influence self-care development in individuals with arthritis, whereas higher pharmacotherapy complexity scores may impair self-care capacity.
METHODS: this cross-sectional study was conducted at a teaching hospital in the Central-West region of Brazil from October to December 2023. Individuals with rheumatoid arthritis undergoing treatment for at least three months were included. A sociodemographic questionnaire, the Appraisal of Self-Care Agency Scale-Revised, and the Pharmacotherapy Complexity Index were used. Analytical statistics were applied using percentiles, the Shapiro-Wilk test, post hoc analysis, ANOVA, and the Kruskal-Wallis test.
RESULTS: the sample consisted of 96 individuals. The mean self-care and pharmacotherapy complexity scores were at intermediate levels, 56.33 and 18.29, respectively. Relationships were identified between dose frequency and self-care development, as well as between overall pharmacotherapy complexity and reduced self-care capacity.
CONCLUSIONS: a high dosage frequency may positively influence self-care development in individuals with arthritis, whereas higher pharmacotherapy complexity scores may impair self-care capacity.